Alan Garber - Articles and news items

Novo Nordisk Logo

Investigational ultra-long-acting insulin degludec reduces hypoglycaemia and improves long-term control

Industry news, News / 27 July 2011 / Novo Nordisk

Ultra-long-acting insulin degludec, lowers blood glucose levels…

Novo Nordisk Logo

Investigational ultra-long-acting insulin degludec reduces hypoglycaemia

Industry news, News / 27 June 2011 / Novo Nordisk

Ultra-long-acting insulin degludec, lowers blood glucose levels with significantly reduced rates of hypoglycaemia (low blood sugar)…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+